Trials / Recruiting
RecruitingNCT05557123
Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)
The ReInforcement of Adherence Via Self-monitoring App Orchestrating Biosignals and Medication of RivoXaban in Patients with Atrial Fibrillation and Co-morbidities: Randomised Control Study(RIVOX-AF Study)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,042 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
RIVOX-AF study is a prospective, multicenter, randomized controlled study in which patients with AF are allocated to medication-app group or conventional treatment group. The App based feed-back algorithm will provide the patients with check taking drug or reminding of taking drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MEDI-app | MEDI-app based feedback algorithm. The app based feedback algorithm will check and remind the patients of taking medication. |
Timeline
- Start date
- 2022-03-10
- Primary completion
- 2025-06-30
- Completion
- 2025-12-31
- First posted
- 2022-09-27
- Last updated
- 2025-01-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05557123. Inclusion in this directory is not an endorsement.